2130869-18-8
Mal-PEG2-VCP-Eribulin
1599440-12-6
893420-59-2
1261609-97-5
1044511-01-4
Benralizumab
1270012-79-7
Efmoroctocog alfa
1227507-92-7
2713439-69-9
tert-Butyl ((S)-1-amino-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamate
1572943-04-4
Tezepelumab
1261456-41-0
62515-68-6
943609-66-3
Vedolizumab
863971-12-4
MMAF-OMe
1380723-44-3
Atezolizumab
159847-82-2
1623109-08-9
2534-03-4
2766584-67-0
1610943-06-0
Emicizumab
1384260-65-4
Aducanumab
More Information:
Check CAS No 2130869-18-8 on External Site
2130869-18-8
eribulin,2130869-18-8
2025-12-26 Discover Mal-PEG2-VCP-Eribulin (CAS No: 2130869-18-8) and related compounds. Ideal for advanced chemical applications. Competitive pricing, fast delivery, and expert support worldwide.